GU5 fundamentals
An in-depth look to Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. operating, investing, and financing activities
GU5 free cash flow for Q1 24 is -441.08 M EUR. For 2023, GU5 free cash flow was 366.53 M EUR and operating cash flow was 575.26 M EUR.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM